Management of Fulminant Hepatitis
Patients with fulminant hepatitis require immediate intensive care unit monitoring with early liver transplantation evaluation, as this is the only definitive life-saving therapy, with transplant survival rates of 75-80% at 1 year compared to spontaneous survival of only 10-25%. 1
Immediate Actions and Monitoring
Transfer the patient immediately to a specialized center with liver transplantation capabilities 1. These patients deteriorate within hours and require:
- Invasive cardiorespiratory and neurological monitoring in an ICU setting 2
- Intracranial pressure monitoring and assessment of cerebral perfusion 1
- Close monitoring of prothrombin time/INR and hepatic encephalopathy grade 3
Etiology-Specific Management
Autoimmune Hepatitis
- Do NOT give corticosteroids if the patient has severe coagulopathy with grade III-IV hepatic encephalopathy - proceed directly to early liver transplantation evaluation 3
- Corticosteroids (1 mg/kg/day) should only be initiated early, ideally before onset of encephalopathy or with low-grade encephalopathy 3
- In the most severe fulminant subgroup, corticosteroids show no benefit 3
Hepatitis B-Related Fulminant Hepatitis
- Initiate antiviral therapy immediately (lamivudine, entecavir, or tenofovir) when prothrombin time deteriorates to INR ≥1.5 or Quick test ≤50% 4, 5
- Antiviral therapy improves survival to approximately 80% compared to poor outcomes without treatment 5
- Timing is crucial - patients started on antivirals at advanced stages have worse outcomes; start promptly 5
- Even if benefit for fulminant cases is debated, antivirals reduce reinfection risk if transplantation becomes necessary 4
Wilson's Disease
- Neuropsychiatric manifestations should NOT preclude transplant evaluation 3
- Requires multidisciplinary team evaluation at a transplant center 3
Supportive Care
Implement the following regardless of etiology:
- N-acetylcysteine administration 2
- Organ support for hemodynamic, renal, and respiratory failure 2
- Albumin dialysis (therapeutic plasma exchange) - improves hemostasis, neurological function, and biochemical stability while awaiting transplantation 6
- Infection prophylaxis with mechanical ventilation as needed 6
Transplant Evaluation Criteria
Use King's College Hospital criteria or Clichy criteria to distinguish patients requiring transplantation from those who may recover spontaneously 7. Refer patients showing signs of progression to acute liver failure to transplant centers as early as possible 4.
Critical Pitfalls to Avoid
- Do not delay transfer to a transplant center - these patients can deteriorate within hours 1
- Do not give corticosteroids to autoimmune hepatitis patients with advanced encephalopathy (grade III-IV) - this delays necessary transplantation 3
- Do not withhold antivirals in severe hepatitis B waiting for "proof" - the evidence favors early treatment and untreated mortality is unacceptably high 5
- Do not assume neurological Wilson's disease patients are not transplant candidates - they can have substantial improvement post-transplant 3